These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8923565)
21. Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity. Fukasawa T; Yasui-Furukori N; Suzuki A; Inoue Y; Tateishi T; Otani K Eur J Clin Pharmacol; 2005 Dec; 61(11):791-5. PubMed ID: 16261363 [TBL] [Abstract][Full Text] [Related]
22. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry. Saletu B; Grünberger J; Linzmayer L; Anderer P Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677 [TBL] [Abstract][Full Text] [Related]
23. Safety evaluation of zotepine for the treatment of schizophrenia. Riedel M; Musil R; Seemüller F; Spellmann I; Möller HJ; Schennach-Wolff R Expert Opin Drug Saf; 2010 Jul; 9(4):659-66. PubMed ID: 20486863 [TBL] [Abstract][Full Text] [Related]
24. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Desta Z; Zhao X; Shin JG; Flockhart DA Clin Pharmacokinet; 2002; 41(12):913-58. PubMed ID: 12222994 [TBL] [Abstract][Full Text] [Related]
25. Adverse effects of zotepine and their relationship to serum concentrations of the drug and prolactin. Kondo T; Otani K; Ishida M; Tanaka O; Kaneko S; Fukushima Y Ther Drug Monit; 1994 Apr; 16(2):120-4. PubMed ID: 7912012 [TBL] [Abstract][Full Text] [Related]
26. In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients. Barnas C; Quiner S; Tauscher J; Hilger E; Willeit M; Küfferle B; Asenbaum S; Brücke T; Rao ML; Kasper S Psychopharmacology (Berl); 2001 Sep; 157(3):236-42. PubMed ID: 11605078 [TBL] [Abstract][Full Text] [Related]
27. Trace analysis of zotepine and its active metabolite in plasma by capillary electrophoresis with solid phase extraction and head-column field-amplified sample stacking. Chou YW; Huang WS; Chen CC; Lin SJ; Wu HL; Chen SH J Chromatogr A; 2005 Sep; 1087(1-2):189-96. PubMed ID: 16130713 [TBL] [Abstract][Full Text] [Related]
28. Influence of propranolol coadministration or cigarette smoking on the kinetics of desmethyldiazepam following intravenous clorazepate. Ochs HR; Greenblatt DJ; Locniskar A; Weinbrenner J Klin Wochenschr; 1986 Dec; 64(23):1217-21. PubMed ID: 2879960 [TBL] [Abstract][Full Text] [Related]
29. Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats. Fuller RW; Snoddy HD J Pharm Pharmacol; 1985 Oct; 37(10):755-6. PubMed ID: 2867152 [TBL] [Abstract][Full Text] [Related]
30. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial. Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193 [TBL] [Abstract][Full Text] [Related]
31. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients. Higashi Y; Momotani Y; Suzuki E; Kaku T Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):8-11. PubMed ID: 2883687 [TBL] [Abstract][Full Text] [Related]
32. Biperiden and piroheptine do not affect the serum level of zotepine, a new antipsychotic drug. Otani K; Hirano T; Kondo T; Kaneko S; Fukushima Y; Noda K; Tashiro Y Br J Psychiatry; 1990 Jul; 157():128-30. PubMed ID: 1975759 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia. Hashimoto K; Sudo T; Hirano M; Motomura H; Tagawa K; Nashiro S; Uemura K; Yoshimoto S Schizophr Res; 2006 Oct; 87(1-3):332-3. PubMed ID: 16797164 [No Abstract] [Full Text] [Related]
34. The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics. Ishizawa Y; Yasui-Furukori N; Takahata T; Sasaki M; Tateishi T Clin Pharmacokinet; 2005; 44(11):1179-89. PubMed ID: 16231968 [TBL] [Abstract][Full Text] [Related]
35. Co-administration of Magnesium Oxide Reduces the Serum Concentration of Hydrophobic Basic Drugs in Patients Treated with Antipsychotic Drugs. Yoshida H; Takahashi M; Honda M; Amayasu H; Ando M Biol Pharm Bull; 2019; 42(6):1025-1029. PubMed ID: 31155577 [TBL] [Abstract][Full Text] [Related]
36. [Effects of zotepine, a psychotropic agent, on the serum uric acid level of inpatients at a psychiatric hospital]. Yoshida H; Kaiya H; Kondo T; Sanpei F; Takeda N; Takeuchi K Yakubutsu Seishin Kodo; 1982 Dec; 2(2):69-76. PubMed ID: 6141682 [TBL] [Abstract][Full Text] [Related]
37. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091 [TBL] [Abstract][Full Text] [Related]
38. Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype. Tanaka M; Ohkubo T; Otani K; Suzuki A; Kaneko S; Sugawara K; Ryokawa Y; Hakusui H; Yamamori S; Ishizaki T Clin Pharmacol Ther; 1997 Dec; 62(6):619-28. PubMed ID: 9433390 [TBL] [Abstract][Full Text] [Related]
39. Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions. Bredberg E; Andersson TB; Frison L; Thuresson A; Johansson S; Eriksson-Lepkowska M; Larsson M; Eriksson UG Clin Pharmacokinet; 2003; 42(8):765-77. PubMed ID: 12846597 [TBL] [Abstract][Full Text] [Related]
40. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]